WHWK

$3.10-0.64%visit website

Whitehawk Therapeutics, Inc.

Market Cap

$177M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.01

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

1.0

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of revenue	0.00	0.00	0.00	0.00	0.00
Research & development	14,345	19,021	17,232	12,893	63,491
Selling, general & administrative	5,201	5,866	6,290	5,216	22,573
Operating income	(19,546)	(24,887)	(23,522)	(18,109)	(86,064)
Interest expense	0.00	0.00
Pretax income			(22,194)	(16,640)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(17,746)	(23,251)	(22,194)	(16,640)	(79,831)
EPS (basic) ($)	(0.26)		(0.32)	(0.20)	—
EPS (diluted) ($)	(0.26)		(0.32)	(0.20)	—
Weighted avg. shares (basic)	69,205		69,237	82,886
Weighted avg. shares (diluted)	69,205		69,237	82,886

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

8 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Sep 10, 2026 accepted 5:02 PM ET	5.02Officer / director change	Document SEC ↗
Aug 6, 2026 accepted 10:08 AM ET	2.02Earnings release	Document SEC ↗
Jun 12, 2026 accepted 4:19 PM ET	5.07Shareholder vote	Document SEC ↗
May 21, 2026 accepted 5:16 PM ET	8.01Other events	Document SEC ↗
May 13, 2026 accepted 8:08 AM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
May 7, 2026 accepted 9:12 AM ET	2.02Earnings release	Document SEC ↗
Mar 12, 2026 accepted 8:02 AM ET	2.02Earnings release	Document SEC ↗
Nov 6, 2025 accepted 8:03 AM ET	2.02Earnings release	Document SEC ↗
Aug 7, 2025 accepted 8:03 AM ET	2.02Earnings release	Document SEC ↗
Jun 13, 2025 accepted 4:39 PM ET	5.07Shareholder vote	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

31%

W/W +4.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-04-16	2026-04-17	Giacobello Scott M.	CHIEF FINANCIAL OFFICER	Sale	141.6K	$4.13	$585K	295.2K	View
2026-04-15	2026-04-17	Giacobello Scott M.	CHIEF FINANCIAL OFFICER	Sale	77.0K	$3.86	$297K	436.8K	View
2026-04-14	2026-04-15	BALL BRYAN	See remarks	Sale	92.5K	$3.64	$337K	397.1K	View
2026-04-13	2026-04-15	BALL BRYAN	See remarks	Sale	26.4K	$3.46	$91K	489.6K	View
2026-04-10	2026-04-13	BALL BRYAN	See remarks	Sale	6,596	$3.43	$23K	516.0K	View

1–5 of 14

1 / 3

Recent News

Whitehawk Therapeutics, Inc. (WHWK) - What Are Analysts Saying About This Stock?

MarketBeat · 2026-11-02

Whitehawk Therapeutics (NASDAQ:WHWK) Stock Falls 4.6% - Here's What Happened

MarketBeat · 2026-10-30

Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development

Yahoo · 2026-10-07

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

Yahoo Finance · 2026-09-14

What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?

Yahoo Finance · 2026-08-28

Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's What You Should Know

Yahoo Finance · 2026-08-26

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

Yahoo Finance · 2026-07-21

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

Yahoo Finance · 2026-07-07

WHWK Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Is Whitehawk Therapeutics (WHWK) One Of The Hot Biotech Stocks Under $5 To Buy?

Yahoo Finance · 2026-06-10

Whitehawk Therapeutics, Inc. Common Stock (WHWK) Stock Price: Oct 30 Close $3.24

Gotrade · 2026-06-03

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

Yahoo Finance · 2026-05-28

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise

Stocktwits · 2026-05-21

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit

Yahoo Finance · 2026-05-20

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing

PR Newswire · 2026-05-13

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-04-16	Giacobello Scott M.	S	141,600	$584,808
2026-04-15	Giacobello Scott M.	S	77,000	$297,220
2026-04-14	BALL BRYAN	S	92,460	$336,554.4
2026-04-13	BALL BRYAN	S	26,389	$91,305.94
2026-04-10	BALL BRYAN	S	6,596	$22,624.28

WHWK

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Whitehawk Therapeutics, Inc. (WHWK)

Reporting Insiders

Factor Profile

Corporate Events (8-K)